No, the Rs. 84,500 Bill Is Not for Papaverine – It’s for Trastuzumab, a Different Injection for Cancer
Subscribe to our WhatsApp Channel A topic that was widely discussed in January this year was that a medicine which could have been released to the market for just Rs. 350, was charged Rs. 76,000 by previous governments. However, the new government announced that they are working on reducing the prices of medicine including this. […]
Continue Reading